NATALIE MOODY: Open Payments
NPI 1740563543 · WINTER HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,554 in 146 payments from 14 companies in 2025. Trend: 2023 $10,337 · 2024 $18,905 · 2025 $11,554
Speaker / faculty: $8,938Food & beverage: $2,425Education: $111Travel & lodging: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $9,531 |
| Teva Pharmaceuticals USA, Inc. | 14 | $379 |
| Lundbeck LLC | 24 | $360 |
| Alkermes, Inc. | 8 | $179 |
| Otsuka America Pharmaceutical, Inc. | 14 | $171 |
| Neurocrine BioSciences, Inc. | 9 | $166 |
| Janssen Pharmaceuticals, Inc | 8 | $151 |
| E.R. Squibb & Sons, L.L.C. | 7 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $142 |
| Tris Pharma Inc | 6 | $111 |
Products named: VRAYLAR, ABILIFY ASIMTUFII, REXULTI, INGREZZA, UZEDY, ARISTADA, INVEGA SUSTENNA, COBENFY.
Industry payments across FL — which companies pay providers there.
